Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19)
Since the outbreak of coronavirus disease 2019 (COVID-19), many researchers in China have performed related clinical research. The quality of the clinical trials was low, and the subjects were primarily non-critical adult patients.
